S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free VM Stock Alerts
C$0.06
-0.01 (-8.33%)
(As of 02:08 PM ET)
Compare
Today's Range
C$0.06
▼
C$0.06
50-Day Range
C$0.05
▼
C$0.09
52-Week Range
C$0.04
▼
C$0.09
Volume
71,000 shs
Average Volume
102,355 shs
Market Capitalization
C$7.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines
VM stock logo

About Voyageur Pharmaceuticals Stock (CVE:VM)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

VM Stock Price History

VM Stock News Headlines

March 13, 2024 | proactiveinvestors.com
Voyageur Pharmaceuticals executes royalty agreement with Rain Cage Carbon
January 3, 2024 | morningstar.com
Voyageur Pharmaceuticals Ltd VM
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
December 21, 2023 | stockhouse.com
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
December 8, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)
October 24, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)
September 14, 2023 | stockhouse.com
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
September 14, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast media
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
September 7, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)
June 20, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)
May 31, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals completes field work at Frances Creek project in British Columbia
May 24, 2023 | finance.yahoo.com
Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs
May 24, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals unveils pioneering agreement with Rain Cage Carbon
May 10, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)
May 4, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)
May 2, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)
April 29, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)
April 28, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)
April 26, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)
April 22, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)
April 21, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)
April 14, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)
April 8, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)
April 6, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)
April 4, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imaging
February 14, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals preparing to launch sales of its first product in Canada
See More Headlines
Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:VM
CUSIP
N/A
CIK
N/A
Web
www.voyageurminerals.ca
Phone
587-779-6166
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-1,400,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-96.50%
Return on Assets
-35.90%

Debt

Debt-to-Equity Ratio
2.79
Current Ratio
0.13
Quick Ratio
0.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C$0.01 per share
Price / Book
5.50

Miscellaneous

Outstanding Shares
138,810,000
Free Float
N/A
Market Cap
C$7.63 million
Optionable
Not Optionable
Beta
0.49
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Brent Willis Bsc.Eng (Age 53)
    President, CEO & Director
    Comp: $131k
  • Mr. Bradley Craig Willis P.Eng. (Age 53)
    Founder, COO & Director
    Comp: $125.5k
  • Mr. Albert Deslauriers
    Chief Financial Officer

Key Competitors

View All Competitors

VM Stock Analysis - Frequently Asked Questions

How have VM shares performed in 2024?

Voyageur Pharmaceuticals' stock was trading at C$0.08 on January 1st, 2024. Since then, VM stock has decreased by 26.7% and is now trading at C$0.06.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Voyageur Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS).

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:VM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media